Comparative evaluation of pirarubicin and adriamycin in gynecologic cancer cell lines-Reference-Cited by-同舟云学术

Comparative evaluation of pirarubicin and adriamycin in gynecologic cancer cell lines

Published:1992-05 Issue:2 Volume:45 Page:164-173
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Nguyen Hoa N.,Sevin Bernd-Uwe,Averette Hervy,Perras James,Untch Michael,Ramos Ronaldo,Donato Daniel,Penalver Manuel

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference29 articles.

1. Chemotherapy;Thigpen,1987

2. Treatment of advanced and recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-platinum and megestrol acetate;Lovecchio;Obstet. Gynecol.,1984

3. Single agent adriamycin followed by combination hexamethylmelamine-cyclophosparmide for advanced ovarian carcinoma;Wharton;Gynecol. Oncol.,1982

4. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group study;Omura;J. Clin. Oncol.,1985

5. Adriamycin methotrexate combination chemotherapy of advanced carcinoma of the cervix. A third look;Trope;Obstet Gynecol.,1980

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Instrument-Based Screening Assay for DNA-Targeted Anticancer Drugs Using Resonance Light Scattering;Combinatorial Chemistry & High Throughput Screening;2010-06-01

2. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models;Phytotherapy Research;2008-06-20

3. Immunosuppression by Discodermolide;Annals of the New York Academy of Sciences;2006-12-17

4. Establishment and characterization of a poorly differentiated lethal human endometrial carcinoma cell line (NOU-1) with karyotype 46,XX;Cancer Genetics and Cytogenetics;2002-10

5. The Analysis of Drug-Induced Cell Cycle Perturbations by Flow Cytometry;Analytical Use of Fluorescent Probes in Oncology;1996